Prophylaxis of urinary tract infections in subjects with spinal cord injury and bladder function disorders current clinical practice;Prophylaxe von Harnwegsinfektionen bei querschnittgelhmten Personen mit Blasenfunktionsstrung aktuelle klinische Praxis

Aktuelle Urologie

Volumn 43, Issue 1, 2012, Pages 55-58

  Pannek, J ^a  

^a SWISS PARAPLEGIC RESEARCH   (Switzerland)

Author keywords

neurogenic bladder dysfunction; prevention; recurrent urinary tract infection; spinal cord lesion

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; CRANBERRY; EUROPE; EVIDENCE BASED MEDICINE; HUMAN; LONG TERM CARE; NEUROGENIC BLADDER; PARAPLEGIA; PH; QUESTIONNAIRE; REHABILITATION CENTER; SPINAL CORD INJURY; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; EUROPE; EVIDENCE-BASED MEDICINE; HUMANS; HYDROGEN-ION CONCENTRATION; LONG-TERM CARE; PARAPLEGIA; QUESTIONNAIRES; REHABILITATION CENTERS; SPINAL CORD INJURIES; TREATMENT OUTCOME; URINARY BLADDER, NEUROGENIC; URINARY TRACT INFECTIONS; VACCINIUM MACROCARPON;

EID: 84856263348     PISSN: 00017868     EISSN: 14388820     Source Type: Journal    
DOI: 10.1055/s-0031-1283787     Document Type: Article

References (24)

1. Biering-Srensen F, Bagi P, Hiby N. Urinary tract infections in patients with spinal cord lesions: treatment and prevention. Drugs: 2001; 61 1275 1287 (Pubitemid 32744408)
2. Hinkel A, Finke W, Btel U et al. Increasing resistance against antibiotics in bacteria isolated from the lower urinary tract of an outpatient population of spinal cord injury patients. Urol Int: 2004; 73 143 148 (Pubitemid 39482725)
3. Sthrer M, Blok B, Castro-Diaz D et al. EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol: 2009; 56 81 88
4. http://www.uroweb.org/fileadmin/tx-eauguidelines/2009/Full/ Urological-Infections.pdf
5. Burgdrfer H, Heidler H, Kutzenberger J et al. Manual Neuro-Urologie und Querschnittlhmung. 4. Auflage Kln Farco: 2007
6. Salomon J, Denys P, Merle C et al. Prevention of urinary tract infection in spinal cord-injured patients: safety and efficacy of a weekly oral cyclic antibiotic (WOCA) programme with a 2year follow-up an observational prospective study. J Antimicrob Chemother: 2006; 57 784 788
7. Biering-Sorensen F, Nielans H M, Dorflinger T et al. Urological situation five years after spinal cord injury. Scand J Urol Nephrol: 1999; 33 157 161 (Pubitemid 29356215)
8. Esclarin De Ruz A, Garcia Leoni E et al. Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury. J Urol: 2000; 164 1285 1289
9. Gnther M, Noll F, Ntzel R et al. Harnwegsinfektprophylaxe. Urinansuerung mittels L-Methionin bei neurogener Blasenfunktionsstrung. Urologe B: 2002; 42 218 220
10. Ditscheid B, Fnfstck R, Busch M et al. Effect of L-methionine supplementation on plasma homocysteine and other free amino acids: a placebo-controlled double-blind cross-over study. Eur J Clin Nutr: 2005; 59 768 775 (Pubitemid 40894941)
11. Virtanen J K, Voutilainen S, Rissanen T H et al. High dietary methionine intake increases the risk of acute coronary events in middle-aged men. Nutr Metab Cardiovasc Dis: 2006; 16 113 120 (Pubitemid 43384708)
12. Lee B B, Haran M J, Hunt L M et al. Spinal-injured neuropathic bladder antisepsis (SINBA) trial. Spinal Cord: 2007; 45 542 550 (Pubitemid 47206957)
13. Hess M J, Hess P E, Sullivan M R et al. Evaluation of cranberry tablets for the prevention of urinary tract infections in spinal cord injured patients with neurogenic bladder. Spinal Cord: 2008; 46 622 626
14. Reid G, Hsiehl J, Potter P et al. Cranberry juice consumption may reduce biofilms on uroepithelial cells: pilot study in spinal cord injured patients. Spinal Cord: 2001; 39 26 30 (Pubitemid 32142457)
15. Wagenlehner F M, Schmiemann G, Hoyme U et al. Nationale S3-Leitlinie Unkomplizierte Harnwegsinfektionen. Empfehlungen zu Therapie und Management unkomplizierter bakterieller ambulant erworbener Harnwegsinfektionen bei erwachsenen Patienten. Urologe A: 2011; 50 153 169
16. Everaert K, Lumen N, Kerckhaert W et al. Urinary tract infections in spinal cord injury: prevention and treatment guidelines. Acta Clin Belg: 2009; 64 335 340
17. Goos K H, Albrecht U, Schneider B. Wirksamkeit und Vertrglichkeit eines pflanzlichen Arzneimittels mit Kapuzinerkressenkraut und Meerrettich bei akuter Sinusitis, akuter Bronchitis und akuter Blasenentzndung im Vergleich zu anderen Therapien unter den Bedingungen der tglichen Praxis. Arzneimittelforschung: 2006; 56 249 257
18. Hachen H J. Oral immunotherapy in paraplegic patients with chronic urinary tract infections: a double-blind, placebo-controlled trial. JUrol: 1990; 143 759 762
19. Waites K B, Canupp K C, Roper J F et al. Evaluation of 3methods of bladder irrigation to treat bacteriuria in persons with neurogenic bladder. JSpinal Cord Med: 2006; 29 217 226
20. Birkhuser F D, Zehnder P, Roth B et al. Irrigation of continent catheterizable ileal pouches: tap water can replace sterile solutions because it is safe, easy, and economical. Eur Urol: 2011; 59 518 523
21. Lee B B, Simpson J M, Craig J C et al. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev: 2007; CD003265
22. Wellens A, Garofalo C, Nguyen H et al. Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex. PLoS One: 2008; 3 e2040 e2040
23. Nolte O. Autogene Vakzination bei therapieresistenten bakteriellen Infektionen. Chemother J: 2009; 18 18 23
24. Wefer B, Ehlken B, Bremer J et al. Treatment outcomes and resource useof patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX) therapy in Germany. World J Urol: 2010; 28 385 390